DOCETAXEL-GEMCITABINE AS SECOND-LINE TREATMENT FOR PATIENTS WITH ADVANCED GASTRIC CANCER

被引：0
|
作者：
D'Alessio, Andrea [1 ]
Amato, Maria Grazia [1 ]
Resta, Davide [1 ]
Sbarufatti, Antonio
Tacchini, Laura [1 ]
Venturi, Cristina [1 ]
Visacarra, Cecilia [1 ]
机构：
[1] Med Oncoematol Policlin S Marco Zingonia BG, Bergamo, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Weekly docetaxel as second-line therapy for patients with advanced breast cancer resistant to previous anthracycline treatment
    Ramos, M
    González-Ageitos, A
    Amenedo, M
    González-Quintas, A
    Gamazo, JL
    Togores, P
    Losada, G
    Almanza, C
    Romero, C
    Gómez-Martín, C
    JOURNAL OF CHEMOTHERAPY, 2003, 15 (02) : 192 - 197
  • [32] Second-Line Treatment for Advanced Pancreatic Adenocarcinoma: Is There a Role for Gemcitabine?
    Daniel M. Girardi
    Luiza Dib B. B. Faria
    Marcela C. Teixeira
    Frederico P. Costa
    Paulo Marcelo G. Hoff
    Gustavo S. Fernandes
    Journal of Gastrointestinal Cancer, 2019, 50 : 860 - 866
  • [33] Docetaxel in combination with gemcitabine as second line treatment in patients with platinum resistant advanced NSCLC
    Gori, Bruno
    Longo, Flavia
    Zivi, Andrea
    Sperduti, Isabella
    Stumbo, Luciano
    Del Signore, Ester
    De Sanctis, Rita
    Quadrini, Silvia
    De Filippis, Lucilla
    Di Seri, Marisa
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S696 - S696
  • [34] DOCETAXEL IN COMBINATION WITH GEMCITABINE AS SECOND LINE TREATMENT IN PATIENTS WITH PLATINUM RESISTANT ADVANCED NSCLC
    Gori, B.
    Longo, F.
    Zivi, A.
    De Sanctis, R.
    Del Signore, E.
    Proietti, E.
    Sperduti, I.
    De Filippis, L.
    Stumbo, L.
    Quadrini, S.
    Di Seri, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 95 - 96
  • [35] A clinical study of docetaxel with or without 5'DFUR as a second-line chemotherapy for advanced gastric cancer
    Maruta, Fukuto
    Ishizone, Satoshi
    Hiraguri, Manabu
    Fujimori, Yoshiro
    Shimizu, Fumiaki
    Kumeda, Shigeyoshi
    Miyagawa, Shinichi
    MEDICAL ONCOLOGY, 2007, 24 (01) : 71 - 75
  • [36] A clinical study of docetaxel with or without 5′DFUR as a second-line chemotherapy for advanced gastric cancer
    Fukuto Maruta
    Satoshi Ishizone
    Manabu Hiraguri
    Yoshiro Fujimori
    Fumiaki Shimizu
    Shigeyoshi Kumeda
    Shinichi Miyagawa
    Medical Oncology, 2007, 24 : 71 - 75
  • [37] A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer
    Ji, Sang Hoon
    Lim, Do Hyoung
    Yi, Seong Yoon
    Kim, Hyo Song
    Jun, Hyun Jung
    Kim, Kyoung Ha
    Chang, Myung Hee
    Park, Min Jae
    Uhm, Ji Eun
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    BMC CANCER, 2009, 9
  • [38] Second-line chemotherapy with paclitaxel for elderly patients with advanced gastric cancer
    Ohba, Akihiro
    Takashima, Atsuo
    Nishiuchi, Takamasa
    Honma, Yoshitaka
    Iwasa, Satoru
    Okita, Natsuko
    Kato, Ken
    Hamaguchi, Tetsuya
    Nagashima, Kengo
    Boku, Narikazu
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [39] A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer
    Sang Hoon Ji
    Do Hyoung Lim
    Seong Yoon Yi
    Hyo Song Kim
    Hyun Jung Jun
    Kyoung Ha Kim
    Myung Hee Chang
    Min Jae Park
    Ji Eun Uhm
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Young Suk Park
    Ho Yeong Lim
    Won Ki Kang
    BMC Cancer, 9
  • [40] Second-line chemotherapy with combined docetaxel and cisplatin for patients with far advanced gastric carcinoma.
    Kunisaki, C
    Akiyama, H
    Otsuka, Y
    Matsuda, G
    Nomura, M
    Hatori, S
    Imada, T
    Togo, S
    Ike, H
    Shimada, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 366S - 366S
12345